Caligan Partners LP is a New York–based SEC-registered investment and advisory firm, specializing in activist and long-biased equity strategies. The firm operates out of New York City with a focus on generating high absolute returns through concentrated, high-conviction positions.
Led by David Johnson, Caligan emphasizes opportunities primarily in the healthcare sector—both public equities and occasionally distressed or special situations. Its portfolio is tightly curated, with relatively few holdings, and the firm often engages directly with company management when it sees an opportunity.
Some of the firm's investments are in Vor Biopharma, Liquidia Technologies, Anika Therapeutics, Outlook Therapeutics, and Teal Bio.
People
- David Johnson, Managing Partner
You last contacted this investor on .